The FDA guidelines aim to create a new pathway for bespoke therapies due to the challenges of conducting large studies.
The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule.
The U.S. Food and Drug Administration plans to give quarterly bonuses to scientific staff for quicker completion of drug ...
The US Food and Drug Administration plans to give bonuses to scientific staff for speeding up drug reviews, according to an ...
FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and one of his deputies, Vinay ...
In a major shift, the US Food and Drug Administration is relaxing a long-standing drug approval requirement for common ...
By Bhanvi Satija and Mariam Sunny Feb 26 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Boehringer ...
The FDA has announced what it calls movement on implementation of the Food Traceability Rule, but some food safety experts ...
The Well News on MSNOpinion
Despite lofty rhetoric, FDA still failing patients and taxpayers
Hope abounds that, after years of rejecting lifesaving medications, the Food and Drug Administration is turning things around ...
Following a Type A meeting, the FDA's Center for Biologics Evaluation and Research has notified Moderna that its biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results